Bacos Anthony 4

What Happened
Anthony Bacos, Stitch Fix’s Chief Product & Technology Officer, exercised options to acquire 50,011 shares (11 shares @ $3.99 and 50,000 shares @ $2.48) and sold 70,011 shares in open-market transactions on June 29, 2026. The exercised shares cost approximately $124,044 in aggregate to acquire; the sales generated about $309,664 in gross proceeds (weighted-average price reported as $4.42). The filing also reports the cancellation/disposition of the derivative interests (the options) at $0 as part of the exercise.

Key Details

• Transaction date: June 29, 2026; Form 4 filed July 1, 2026 (timely filing).
• Options exercised (code M): 11 shares @ $3.99 ($44) and 50,000 shares @ $2.48 ($124,000) — total acquired via exercise: 50,011 shares, total cash paid ≈ $124,044.
• Sales (code S): 20,000 shares (weighted avg price reported; proceeds $88,450) and 50,011 shares (weighted avg price reported; proceeds $221,214); total sold = 70,011 shares, total proceeds ≈ $309,664.
• Sale price ranges (weighted averages noted in footnotes): sales executed across prices from $4.35 to $4.495 per share and $4.35 to $4.51 per share for the respective blocks; the filing offers to provide exact per-trade breakdown on request.
• Footnotes: One or more sales were made pursuant to a Rule 10b5-1 plan established March 17, 2026. Vesting schedule for the underlying option is noted in the filing (see footnote F4).
• Shares owned after the transaction: not specified in the summary data provided here; see the full Form 4 for post-transaction holdings.

Context

• The filing shows option exercises and same-day open-market sales. Exercising options and promptly selling shares is common (converts option value to cash); because more shares were sold (70,011) than were acquired via exercise (50,011), some sold shares likely came from prior holdings as well.
• Sales executed under a 10b5-1 trading plan indicate pre-arranged automated sell instructions, which are typically used to avoid trading on material nonpublic information.
• These are executive-level transactions (company officer) and are factual disclosures of trades; they should not be read as definitive signals about company performance. For full details, including exact post-transaction holdings and per-trade prices, consult the complete Form 4 (Accession 0001628280-26-046637).